Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Regeneron Pharmaceuticals Inc    REGN   US75886F1075

Delayed Quote. Delayed Nasdaq - 09/02 04:00:01 pm
359.5 USD   +2.58%
2h agoDJMARKET SNAPSHOT : S&P 500 Falls Back Under 2,000 As Stocks Slip
4h ago S&P 500 MOVERS : Wynn, spls
4h ago NASDAQ 100 MOVERS : Wynn, spls
 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
08/26/2014 08/27/2014 08/28/2014 08/29/2014 09/02/2014 Date
354.05(c) 350.01(c) 346.92(c) 350.455(c) 359.5 Last
668 654 439 481 401 786 525 535 1 515 567 Volume
+1.76% -1.14% -0.88% +1.02% +2.58% Change
More quotes
Company
Regeneron Pharmaceuticals, Inc. operates as a biopharmaceutical company. It discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron markets medicines for eye diseases, colorectal cancer and a rare inflammatory condition and... 
Sector
Pharmaceuticals
Calendar
09/02 | 08:30amSpecial Situation
Surperformance© rating of Regeneron Pharmaceuticals
Trading Rating : Investor Rating :
More about the company
Chart REGENERON PHARMACEUTICALS
Duration : Period :
Regeneron Pharmaceuticals  Technical Analysis Chart | REGN | US75886F1075 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 2 809 M
EBIT 2014 1 046 M
Net income 2014 423 M
Finance 2014 1 141 M
Yield 2014 -
Sales 2015 3 499 M
EBIT 2015 1 461 M
Net income 2015 771 M
Finance 2015 2 360 M
Yield 2015 -
PER 2014 94,96
PER 2015 53,64
EV / Sales 2014 12,2x
EV / Sales 2015 9,45x
Capitalization 35 419 M
More Financials
Latest news on REGENERON PHARMACEUTICALS
2h agoDJMARKET SNAPSHOT : S&P 500 Falls Back Under 2,000 As Stocks Slip
4h ago S&P 500 MOVERS : Wynn, spls
4h ago NASDAQ 100 MOVERS : Wynn, spls
5h agoDJMARKET SNAPSHOT : S&P 500 Dips, But Apple, Staples, Tesla Pop
6h agoDJMARKET SNAPSHOT : S&P 500 Flat After ISM Data; Staples, Regeneron Pop
7h ago REGENERON PHARMACEUTICALS : Sanofi : and Regeneron Present Detailed Positive Res..
1d ago Pricing is key for new heart drugs challenging cheap generics
5d ago REGENERON PHARMACEUTICALS : Assigned Patent
08/25 NASDAQ 100 MOVERS : Intu, gild
08/20 REGENERON PHARMACEUTICALS : Patent Issued for VEGF Antagonist Formulations for I..
08/20 REGENERON PHARMACEUTICALS : Researchers from Regeneron Pharmaceuticals Report on..
08/20 REGENERON PHARMACEUTICALS : EYLEA® aflibercept Injection Receives EU Approval fo..
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
Regeneron Pharmaceuticals  : Income Statement Evolution
More Financials
EPS Revisions
Regeneron Pharmaceuticals  : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF